MS Amlin launches Phoenix 2 Re ILS vehicle
January 7 2022 by Karen Lai
-
‘Bright future’ for structured solutions in APAC as awareness grows: Guy Carpenter
- November 4
Bridging the gap between risk appetites of cedents and reinsurers is a key theme for the market, says Guy Carpenter’s Hussain Ahmad.
-
Expanding into non-ILS capital pools is a priority: MS Amlin
- November 4
William Ho, MS Amlin Asia Pacific CEO, discusses the evolving regional reinsurance landscape, the impact of recent cat losses, and the reinsurer’s strategic growth plans in APAC.
-
Policy support and RBC to help insurers tackle emerging challenges: Michael Wong
- September 24
The government has introduced policies and a new capital regime to help the sector tackle these challenges, said acting financial secretary Michael Wong inaugurating EAIC 2024.
-
Leadenhall and Bennelong launch cat bond fund for Australia and New Zealand
- August 21
The two firms had in October last year joined hands to distribute ILS strategies to institutional investors in the region.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
